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The purpose of the study was to assess a large representative sample of cancer patients on distress levels, common psychosocial
problems, and awareness and use of psychosocial support services. A total of 3095 patients were assessed over a 4-week period with
the Brief Symptom Inventory-18 (BSI-18), a common problems checklist, and on awareness and use of psychosocial resources. Full
data was available on 2776 patients. On average, patients were 60 years old, Caucasian (78.3%), and middle class. Approximately, half
were attending for follow-up care. Types of cancer varied, with the largest groups being breast (23.5%), prostate (16.9%), colorectal
(7.5%), and lung (5.8%) cancer patients. Overall, 37.8% of all patients met criteria for general distress in the clinical range. A higher
proportion of men met case criteria for somatisation, and more women for depression. There were no gender differences in anxiety
or overall distress severity. Minority patients were more likely to be distressed, as were those with lower income, cancers other than
prostate, and those currently on active treatment. Lung, pancreatic, head and neck, Hodgkin’s disease, and brain cancer patients were
the most distressed. Almost half of all patients who met distress criteria had not sought professional psychosocial support nor did
they intend to in the future. In conclusion, distress is very common in cancer patients across diagnoses and across the disease
trajectory. Many patients who report high levels of distress are not taking advantage of available supportive resources. Barriers to such
use, and factors predicting distress and use of psychosocial care, require further exploration.
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Psychosocial distress in cancer patients has been identified as a
significant and ongoing problem. The National Comprehensive
Cancer Network (NCCN) Distress Management Panel has defined
distress as
ya multi-determined unpleasant emotional experience of a
psychological (cognitive, behavioral, emotional), social, and/or
spiritual nature that may interfere with the ability to cope
effectively with cancer, its physical symptoms and its treatment.
Distress extends along a continuum, ranging from common
normal feelings of vulnerability, sadness and fears to problems
that can become disabling, such as depression, anxiety, panic,
social isolation, ad spiritual crisis. (National Comprehensive
Cancer Network, 2002)
Previous studies have documented that approximately one-third
of all oncology patients will experience significant levels of distress
associated with diagnosis and treatment of cancer, which warrants
psychosocial treatment (Derogatis et al., 1983; Stefanek et al., 1987;
Zabora et al., 1997; Sellick and Crooks, 1999; Zabora et al., 2001a;
Carlson and Bultz, 2003b). Also well documented, using rigorous
methodology, is the ability of various psychosocial treatments to
alleviate distress levels and improve quality of life in cancer
patients, reviewed in several papers and meta-analyses (e.g.
(Cunningham, 1995; Meyer and Mark, 1995; Bottomley, 1997;
Fobair, 1997; Iacovino and Reesor, 1997; Fawzy et al., 1998;
Fawzy, 1999; Blake-Mortimer et al., 1999; Cunningham, 2000;
Schneiderman et al., 2001; Carlson and Bultz, 2003a).
Interventions usually assume one of four common forms:
psychoeducation, cognitive-behavioural training (group or indivi-
dual), group supportive therapy, and individual supportive therapy.
As well, they are usually targeted to one of three points on the
illness trajectory: diagnosis/pretreatment, immediately post-treat-
ment or during extended treatment (such as radiotherapy or
chemotherapy), and disseminated disease or death (Schneiderman
et al., 2001). Certain modalities of treatment have been shown to be
more efficacious at one or more of these time periods. For example,
psychoeducation may be most effective during the diagnosis/
pretreatment time period, when patient information needs are high.
However, for later stage adjustment with more advanced disease,
group support may be more effective (Blake-Mortimer et al., 1999),
while cognitive-behaviour techniques such as relaxation, stress
management and cognitive coping may be most useful during
extended treatments (Fawzy, 1995; Bottomley, 1997).
Several agencies, both American and International, have
developed guidelines for psychosocial care, which include screen-
ing guidelines (see Carlson and Bultz (2003b) for an overview of
distress screening issues). The Canadian Association of Psychoso-
cial Oncology has published a book of Standards which details
principles of practice, professional issues, and organization and
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lstructure of psychosocial oncology programmes (Canadian Asso-
ciation of Psychosocial Oncology, 1999). Principle 7 states that
‘psychosocial service needs of patients and families are assessed
systematically using appropriate tools’ (p. 5). The National
Comprehensive Cancer Network (NCCN) and the American
Society of Clinical Oncology (ASCO) also have guidelines
regarding the identification and management of distress (available
at: http://www.nccn.org/physician_gls/index.html). The NCCN
guidelines were developed by a Distress Management Panel that
included many researchers and clinicians directly involved in
major American screening programmes. The standards of care
developed by this group state that: ‘All patients should be screened
for distress at their initial visit, at appropriate intervals, and as
clinically indicated.’ (DIS-3) (National Comprehensive Cancer
Network, 2002). They go on to delineate clinical practice guidelines
for the treatment of distress.
Where there has often been a disconnect, however, is in the
ability of psychosocial oncologists to use information about
distress levels obtained through routine screening of patients,
and to direct those patients identified as in need of services to the
appropriate sources of care. This idea of screening followed by
appropriate triage is not new in psychosocial oncology, but rarely
happens in routine clinical practice. Researchers at Johns Hopkins
University have developed a comprehensive psychosocial oncology
screening programme that assesses all patients at the point of entry
into the cancer care system. Based on this assessment of emotional
distress and practical problems, the patients who need support are
contacted personally within 48h, and those who do not indicate
significant current need are provided with information regarding
the options for social and psychological care for future consulta-
tion (Zabora et al., 2001b).
Unfortunately, even routine psychosocial screening of patients is
not the norm in terms of care of cancer patients. More commonly,
patents are either self-referred, or referred by a member of the
medical treatment team who becomes alerted to the patient’s
distress in the course of clinical care. This can potentially result in
missing a large proportion of patients who may be in need of care,
but who are either too distressed or without the instrumental
resources to find their way through the often confusing medical
system to reach psychosocial care. In addition, patients themselves
may be so preoccupied with the physical components of their
cancer that they may be unaware of the seriousness of the level of
their own psychosocial distress, and potentially unaware that help
is available to treat these symptoms. It may be the case, then, as a
result of this unsystematic referral system, that the most
disadvantaged patients may be the least likely to get necessary
care.
In order to investigate this possibility, and also to comprehen-
sively assess the most common psychosocial problems reported by
a population of patients, we sought to assess every patient who
visited a large urban tertiary cancer centre over a 4-week period of
time in January of 2003. Patients with any diagnosis and all
treatment stages were included in the screening programme, in
order to capture a cross-sectional snapshot of patients that could
be generalised to the cancer centre population at large. A
substantial sample would also allow comparisons between men
and women, patients from different ethnic backgrounds, with
different types of cancer, and at varying stages of treatment.
METHODS
Subjects and setting
All patients over the age of 18 years who visited the Tom Baker
Cancer Centre for any reason (diagnosis, new patient consultation,
treatment, follow-up) during the course of the concentrated
screening effort were eligible to participate in the screening
programme. No restrictions were placed on age, ethnicity, gender,
type of cancer, stage of illness, or disability. Patients who were
unable to communicate in English were noted as such and an
incomplete questionnaire was submitted with this proviso. It was
ensured that each patient was assessed only once.
The Tom Baker Cancer Centre is a large regional tertiary cancer
centre that serves a population of approximately 2 million people,
with approximately 3500 new patients yearly, and 32000 annual
patient visits. The Department of Psychosocial Resources at the
TBCC is one of the largest in Canada, employing six full-time and
two part-time psychologists, two full-time and two part-time
clinical social workers, as well as a number of research staff.
Instruments
Demographic and Cancer History Questionnaire The first few
questions collected standard demographic and disease-related
information.
Psychosocial Questionnaire The next section asked a series of
questions regarding awareness and use of the Department of
Psychosocial Resources at the TBCC. Questions were developed by
the psychosocial staff and pretested on a group of patients for
clarity and ease of understanding. Included questions are listed in
Figure 1.
Problem checklist The following section included the patient
problem checklist with 22 items, adapted from that used by the
Johns Hopkins research group to fit the local setting. Patients were
instructed to check off all problems they currently have or expect
to have.
Brief Symptom Inventory – 18 (BSI–18) Published in 2001
(Derogatis, 2001), this short 18-item instrument is the latest in
an integrated series of test instruments designed to measure
psychological distress. Shortened from the original Symptom
Checklist (SCL-90-R; Derogatis, 1983), the 53-item Brief Symptom
Inventory (BSI) (Derogatis, 1993), and now the 18-item version
have been normed for use with cancer patients. The BSI and the
SCL-90 have been used extensively with medical populations,
including cancer patients, and have demonstrated high levels of
sensitivity and specificity in screening for psychological distress
(Zabora et al., 1990;Carlson and Bultz, 2003b). The BSI-I8 was
developed specifically as a highly sensitive and efficient screen for
psychiatric disorders and psychological distress. The BSI-18 is
highly reliable ad valid and is significantly correlated with the BSI.
The instrument yields three subscale scores: Somatization,
Depression and Anxiety, with internal consistencies ranging from
0.74 to 0.89, and correlations with the BSI ranging from 0.91 to
0.96. A composite score, the General Severity Index (GSI), also
shows similar high levels of reliability. Average completion time is
1–3min. The BSI-18 is the version that the Johns Hopkins group
has been recently using in their screening programme, and on
which they have published norms from a large sample of patients
(Zabora et al., 2001b).
In addition to continuous scoring on each subscale, cutoff scores
are recommended for ‘caseness’ of each subscale and the GSI
scores for cancer patients, based on the guidelines in the manual.
Individuals who score at or over the cutoff values are considered to
be experiencing levels of distress that require psychosocial
intervention. Criteria for ‘caseness’ vary between men and women
for anxiety and somatization, but not for depression.
Procedures
The assessments were collected over a 1-month period as a
‘snapshot’, or cross-sectional analysis of all patients visiting the
TBCC during this time period, both new and follow-up, across all
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lclinics. Ethical approval was obtained from the local Research
Ethics Board, and all affected departmental managers consented in
writing to cooperate in the data collection.
Four main departments were targeted with a view to maximising
patient accrual: (a) Outpatients; (b) Medical Daycare; (c) Radiation
Therapy; and(d) Laboratory. Six staff were stationed in the four
departments on a full-time basis during the month of data
collection. Patients were approached when they arrived in each
area, and given the assessment package to complete in the waiting
area. The package consisted of a patient information sheet for
them to keep (signed informed consent was not required by the
local Research Ethics Board, as all responses were provided in
anonymity), the questionnaires, an envelope, and a pin consisting
of a ribbon with a ‘happy face’ sticker. Research assistants were
available to help patients complete the packages and answer
questions.
If patients chose not to complete the questionnaires, they
were asked to check off their reason for declining at the top
of the questionnaire (or the RA asked about their reason and
checked the box for them) and the incomplet questionnaires were
submitted. Once a patient had completed and submitted the
questionnaires, they were asked to wear the ‘happy face’ pin
when at the centre, to alert research assistants not to approach that
patient again. Packages were collated and counted at the end
of each day and stored in locked filing cabinets for later data
analysis.
Psychosocial Questionnaire Questions 
Prior to this survey, were you aware that a department exists at the Tom Baker whose purpose is to focus on 
your emotional and social needs?  
 YES   NO 
Have you ever used the services of the Psychosocial Resources Department in the past?
 YES   NO 
Are you currently using the services of the Psychosocial Resources Department? 
 YES   NO 
Do you plan to use the services of the Psychosocial Resources Department in the future? 
 YES   NO 
If you have used the services of the Psychosocial Resources Department, who in your family used the 
services (check all that apply)? 
 Myself   Spouse/partner   Children    Other: ______________________ 
If you have used the services of the Psychosocial Resources Department, what specific services did you or 
your family use (check all that apply)? 
 Individual counselling   Couples counselling   Group counselling 
 Resource/financial counselling   Other (describe)__________________________ 
If you have NOT used the services of the Psychosocial Resources Department, what are some of the reasons 
you have not done so (check all that apply)? 
 Didn’t know about it   I feel that there is a stigma attached to it 
 Don’t think I need help   Don’t like the name of the department 
 Not sure if it could help   Don’t want to come back to the hospital 
 Trouble with transportation   Parking 
 Too far to travel   Other (please describe):____________________ 
______________________________________________________________________ 
Whether or not you have used the services of the Psychosocial Resources Department, where are you getting 
support during your cancer experience (check all that apply)? 
 Family members   Friends   No support 
 Religious community members   Outside counsellor 
 Religious leader   Neighbours 
 Other Cancer Centre staff   Department of Psychosocial Resources 
Figure 1 Psychosocial Questionnaire Questions.
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lRESULTS
Subjects
Questionnaires were collected from 3095 patients over the course
of the 4 weeks of screening. Of these, 319 (approx. 10%) declined
to complete the questionnaires. The reasons for this include
the following: not interested (43.5% of decliners), cannott
read English (13.2%), feeling too sick (11%), too rushed (10.7%),
too tired (6.6%), and other (15.4%). This left a sample of 2776
patients (90%) who completed the questionnaires. The statistics
kept by the TBCC for visits in the month of January indicated that
there were 750 new patient visits, and 3015 follow-up visits, for a
total of 3765 patient visits. This would indicate that we captured
82.2% of all patients, with full data on 73.7%. However, these
numbers may be conservative estimates, as the statistics report
visits, not individual patients. Therefore, if a patient visited more
than once during the month, each visit would be recorded as a
separate statistic.
Demographic characteristics of the sample are presented in
Table 1. The sample was 52.2% of female subjects, an average age
of 60 years, with mean levels of 13 years education, and 3 years
postdiagnosis. They were primarily from European, British, or
Canadian origins (78.3%), and income was fairly equally
distributed, with 41.8% earning less than $40000 year annual
household income, 29.2% between $40 and $80 thousand, and 18%
earning over $80000.
In terms of cancer type, the largest group was breast cancer
(23.5%), followed by prostate (16.9%), colorectal (7.5%), and lung
(5.8%). Most other types of cancer were also represented, as
summarised in Table 2. The primary reason for the visit was
identified as follow-up in 51.9% of the cases, with tests (10.9%),
chemotherapy (9.6%), and radiotherapy (9.0%) being the next
most common. 7.7 % of patients were at the Centre for their first
visit, and the remainder were either picking up medication (1.6%),
had another reason (8.7%), or did not check off a reason for the
visit (0.7%).
Distress
The mean scores for the three subscales and the GSI on the BSI-18
are presented in Table 3. The mean scores as well as the percentage
of each group meeting the criteria for ‘caseness’ are displayed.
Overall, close to 38% of the entire sample met the caseness criteria
for Global Severity, with some variations in the prevalence of each
subscale such that overall somatisation was the most common
(39.7%), followed by depression (36.3%), and anxiety (30.3%).
Men were more likely than women to be cases of somatisation
(w
2¼5.85, Po0.05), whereas women were more likely to be cases
of depression (w
2¼15.64, Po0.001). No gender differences in
anxiety or the overall severity were found.
Further investigation of distress levels by ethnicity, income, type
of cancer, and reason for visit are presented in Table 4. For these
analyses, continuous GSI scores were compared between the
categorical groups using ANOVA. Patients representing minority
ethnicities were more distressed than those of Canadian/British/
European descent (F¼27.98, Po0.001), as were those from lower
income households (F¼24.63, Po0.001). Patients with prostate
cancer were less distressed than patients with breast cancer
(Po0.001) and patients with other diagnoses (Po0.001; overall
F¼35.32), and those on active treatment were more distressed
than those on follow-up treatment (F¼3.72, Po0.05).
Table 1 Demographics
Mean (years) s.d.
Age 60.00 14.69
Education 13.18 3.42
Duration of illness 3.26 4.59
Number Valid percentage
Gender
Female 1451 52.2
Ethnicity
European 896 32.3
Canadian 703 25.4
British 571 20.6
E and SE Asian 121 4.4
Aboriginal 31 1.1
South Asian 27 1.0
Ethnicity missing 349 12.6
Ethnicity other 74 2.7
Income
o10000 145 5.2
10000–20000 354 12.8
20000–40000 659 23.8
40000–60000 493 17.8
60000–80000 316 11.4
80000–100000 203 7.3
o100000 296 10.7
Missing 306 11.0
Table 2 Type of cancer
Type Number Percentage
Breast 652 23.5
Prostate 469 16.9
Colorectal 209 7.5
Lung 162 5.8
Lymphoma (non-Hodgkin’s) 156 5.6
Leukemia 109 3.9
Ovarian 88 3.2
Brain 81 2.9
Multiple meyeloma 70 2.5
Melanoma 67 2.4
Testicular 58 2.1
Cervix 53 1.9
Uterine 44 1.6
Hodgkin’s disease 41 1.5
Other 430 15.5
Missing 83 3.0
Table 3 BSI-18 scores overall and by gender
Mean score s.d. Percent meeting caseness criteria
Somatisation 4.03 4.21 39.7
Men 3.77 4.17 42.2
a
Women 4.26 4.23 37.4
Depression 3.59 4.48 36.3
Men 3.25 4.34 32.2
a
Women 3.88 4.58 39.8
Anxiety 3.83 4.53 30.3
Men 3.12 4.08 31.5
Women 4.46 4.80 29.3
GSI 11.34 11.52 37.8
Men 10.03 11.01 37.6
Women 12.49 11.84 37.9
aMen statistically different per cent of cases than women, Po0.01.
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lThe association of these variables with distress scores from a
multivariate perspective was also explored using multiple linear
regression analyses. The demographic variables of age, gender,
education, ethnicity (Canadian/British/European vs Other), and
income (o40000 vs o40000) were first added in one block,
followed by the disease-related variables of the type of cancer
(breast or other), duration of illness, and reason for visit (follow-
up or other). All of these variables were included in the final best
fitting model (F¼12.33, Po0.001), except years of education and
type of cancer. Possibly, the dummy variables in the cancer
category of breast or other were too broad to detect differences.
Thus, variables in the model included: age (t¼ 5.36, Po0.001),
sex (t¼2.91, Po0.001), ethnic background (t¼4.17, Po0.001),
income (t¼ 5.38, Po0.001), duration of illness (t¼2.40,
Po0.05), and reason for visit (t¼ 2.60, Po0.01). Directionality
indicated that younger age, female sex, ethnicity other than
Canadian/British/European, lower income, longer duration of
illness, and not being on follow-up were all independently
associated with higher distress levels. Longer duration of illness,
in this case, may possibly be a proxy for more advanced disease or
disease recurrence.
Distress comparisons by disease site
Distress levels in this sample were compared to those reported on
the BSI-18 from the Johns Hopkins Oncology Centre as published
by Zabora et al. (2001a). These are displayed in Table 5. The
Pearson product–moment correlation coefficient between Johns
Hopkins and Tom Baker values was highly significant in a positive
direction (r¼0.764, Po0.001), indicating a high degree of
similarity in the distress levels of patients within different cancer
diagnoses at both institutions. Lung patients endorsed the highest
levels of distress, followed by a cluster containing pancreatic,
Hodgkin’s lymphoma, brain, head and neck, leukaemia, and
lymphoma. The cluster of diagnoses with the lowest levels of
distress included gynaecological, breast, melanoma, colon and
prostate cancers.
Common problems
The top problems endorsed by patients are depicted in Figure 2.
The most frequent problem endorsed was fatigue (48.5%), followed
at much lower rates, almost equally by pain (26.4%), managing
emotions/stress (24.8%), depression (24.0%), and anxiety (24.0%).
The modal number of problems endorsed by patients was 3, and
the correlation between number of problems endorsed and BSI-18
GSI score was r¼0.57, Po0.001.
Awareness and use of psychosocial resources
When asked if they were aware of the existence of a specific
department whose purpose was to address the emotional and
social needs of patients, 68.1% indicated awareness of such a
department. When looked at by reason for visit, more patients on
active treatment (72.1%), and follow-up (73.9%), than those on
their first visit (49.8%) were aware of the Psychosocial Resources
Department. In terms of usage, 17.8% indicated use of the
department in the past, 6.7% endorsed currently using the
services, and 20.4% said they planned to use psychosocial
resources in the future. These three combined (past, current, and
future users) constituted 36.4% of the sample.
In terms of who used the services, most commonly it was the
patients themselves (18.8% of total sample), followed by a spouse
(7.4%) and children (2.6%). The highest use of services was for
individual counselling (14.5%), followed by couples counselling
(4.7%), group (3.0%), and resource/financial (3.0%).
Patients who did not use the service were also asked the reasons
for not using it. The main reason for not using Psychosocial
Resources was the perception of not needing any help (44.1% of
those who replied to this question), followed by not knowing about
the services provided (19.2%). Of note is that almost no patients
reported the name of the department (0.4%), or any stigma
Table 4 BSI GSI scores by demographic and disease variables
Mean score s.d.
Ethnicity
Canadian/British/European 10.6 10.8
Other 15.4
a 13.7
Income
o40000 12.4
b 12.0
440000 9.9 10.4
Type of cancer
Breast 12.0 12.2
Prostate 7.3
c 8.8
Other 11.8 11.2
Reason for visit
First visit 10.6 9.4
Active treatment 11.8
d 11.8
Follow-up 10.6 11.1
aOther ethnicities more distressed than Canadian/British/European.
bLower income
more distressed than higher.
cBreast and other diagnoses more distressed than
prostate.
dActive treatment more distressed than follow-up patients.
Table 5 Percentage of distress ‘cases’ by cancer diagnosis
Site
Johns Hopkins
(Zabora et al, 2001a) TBCC
Lung 43.4 57.6
Brain 42.7 45.3
Hodgkin’s 37.8 48.7
Pancreas 36.6 52.2
Lymphoma 36.0 42.5
Liver 35.4 NA
Head and Neck 35.1 48.6
Adenocarcinoma (unknown primary) 34.9 NA
Breast 32.8 35.4
Leukaemia 32.7 45.5
Melanoma 32.7 34.4
Colon 31.5 32.1
Prostate 30.5 26.6
Gynaecological 29.6 38.3
48.5
26.4 24.8 24 24 22.8
20.6
13.5 12.9 11.8
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Figure 2 Problems endorsed (percentage of respondents).
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lattached to it (0.7%), as a deterrent to using the services. Other
reasons included it being too far to travel (8.5%), parking
problems (8.1%), and not being sure if the services would help
(8.4%).
Use of the Psychosocial Department was also analysed by
distress caseness, cancer site, ethnicity, and reason for visit.
Patients with breast cancer were higher utilisers of psychosocial
care (45.1% of those who indicated past, present, or future use),
compared to those with prostate cancer (22.5%), and other types
(37.6%). It was also more common for users to be from another
ethnicity (45.2%), rather than Canadian/European/British (35.6%).
Interestingly, the rate of endorsement of using psychosocial
resources was higher in those attending for their first visit
(45.0%), than for those in active treatment (35.0%), or follow-up
(33.6%). This may be due to the intention of the newer patients to
use the services in the future, which may not translate into actual
use. It may also mean that the screening programme gave them
information about psychosocial services they otherwise would not
have had until later in their treatment.
Finally, the relationship of distress caseness to psychosocial
use was investigated. Of interest is that almost half of all
patients identified as suffering significant distress levels on the
BSI-18 have not used psychosocial resources in the past or present,
and do not intend to use the services in the future. This percentage
is highest for cases of somatisation (50.5% of cases not using
psychosocial), followed by depression (42.5%) and anxiety
(41.7%).
Other sources of support were also investigated, with high levels
of endorsement of receiving support from family (87.5%) and
friends (73.7%). These were followed by neighbours (24.2%),
religious community members (22.3%), and other cancer centre
staff (16.5%). Some patients also endorsed getting no support
(4.5%). The relationship between distress and these other types of
support was investigated by looking at the per cent of patients who
identified as distress cases on the GSI within each group.
Interestingly, there were no differences in the percentage of cases
and noncases who indicated receiving support from family,
friends, or community members. However, those who sought
support from the Department of Psychosocial Resources
(w
2¼35.13, Po0.001), or an outside counsellor (w
2¼6.35,
Po0.05), were more likely to be identified as distress cases than
those who did not seek such support. Specifically, 57.6% of those
who visited psychosocial resources were identified as distress
cases, and 49.5% of those who saw an outside counsellor. This is
compared to an even distribution of about 37–40% of those both
receiving and not receiving support from family, friends, and
community members being identified as cases. This would seem to
indicate that a greater proportion of those experiencing the most
distress seek out professional, rather than community support.
Nonetheless, even within this group, some 50% of the distress
cases do not seek professional support.
DISCUSSION
This study confirmed that a significant proportion of a large
representative sample of diagnostically heterogeneous cancer
patients self-reported clinical levels of distress, including anxiety
and depression, across the disease continuum. Patients in this
sample also reported high levels of fatigue and pain. A critical
finding is that over one-third of all patients, whether currently in
treatment or on long-term follow-up, continued to report
significant levels of distress. This magnitude of distress is very
similar to other reports, and also similar in terms of distress levels
within different cancer diagnoses (Zabora et al., 2001a). The most
distressed groups of patients included lung, pancreatic, Hodgkin’s
lymphoma, brain, head and neck, leukemia, and lymphoma
patients.
Distress was also related to demographic characteristics
including younger age, female gender, minority ethnicity, lower
income, longer duration of illness, and being on active treatment
or newly diagnosed. These latter two items may appear to be in
opposition to one another: that is, having a new cancer diagnosis
and/or being on active treatment would imply a shorter duration
of illness, yet longer duration of illness was also independently
predictive of higher distress. This may be consistent with a U-
shaped distress curve over the course of the disease continuum,
with higher levels of distress around the time of diagnosis, which
abate somewhat following active treatment, but may rise as time
goes by (Hanson et al., 2000). The ‘duration of illness’ variable may
serve as a marker for disease recurrence or progression, as it is less
likely that patients who were out of treatment, yet well, would be
visiting the centre in great numbers. Unfortunately, accurate data
on disease stage with which to verify this possibility is not
available. This would be consistent with another study that found
lower quality of life scores in palliative patients, compared to those
in other stages of the disease continuum (Zabora et al., 1997).
However, although quality of life was worse in these palliative
patients, this study did not find significant differences in overall
distress across the disease trajectory.
Previous reports indicate that younger patients may suffer
higher levels of distress (Wenzel et al., 1999; Carlson and Bultz,
2002), theorised to be due to a larger disruption of social and
familial roles at earlier developmental stages, such as raising small
children and establishing careers. It may also be perceived as less
‘fair’ for a younger person to be struck by cancer, thereby causing
additional distress. As well, patients at earlier life stages may have
more limited life experience and problem-solving skills related to
such a traumatic event. Similarly, historically socially disadvan-
taged groups such as women, minorities, and lower income earners
also report higher distress levels as in this sample, perhaps
illustrating that dealing with cancer involves more challenges for
these groups. However, it is also possible that these disadvantaged
groups would report higher distress levels in the general public as
well, suggesting that a cancer diagnosis may add to an already
heightened level of distress.
The high level of fatigue in this sample was also noteworthy,
with almost half of all patients reporting fatigue as a problem. This
is also consistent with other studies, and fatigue is beginning to be
recognised as one of the most significant and long-term
consequences of cancer and its treatment (Hann et al., 1997;
Hann et al., 1999; Knobel et al., 2000; Okuyama et al., 2001). Of
note is that almost half of all patients who were identified as
suffering significant distress had not used psychosocial resources
in the past or present, and did not intend to use the services in the
future. This is of concern given that many empirically supported
treatments for distress in cancer patients are widely available (for
reviews, see Fawzy et al., 1995; Meyer and Mark, 1995; Bottomley,
1997; Iacovino and Reesor, 1997; Fawzy, 1999; Carlson and Bultz,
2003a). However, even though few sought formal professional care,
most patients did endorse seeking support from family and
friends. It appeared that those who were most in distress were
more likely to seek professional, rather than community, support,
which suggests that some people who most needed care were
getting appropriate services.
There are certain methodological advantages that make this
study unique. First, we managed to capture over 80% of eligible
patients who passed through the centre over the designated time
period (and perhaps more), which bolsters the generalisability of
these results. The sample included a heterogeneous group of
patients both in terms of type of cancer, and in terms of time since
diagnosis and treatment phase, thus allowing direct comparisons
between diagnoses and treatment phases. One of the major
limitations of this study is its cross-sectional nature. It is not
possible to draw any causal conclusions from the data, or to get a
sense of how the same patients would fare prospectively as they
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a Canadian population, the generalisability of this data to other
countries is not known. However, the similarities between this data
and other reports from the USA and Europe help to bolster
confidence in its universality.
The data also suggest that more needs to be done to change the
face of clinical oncology practice when it comes to treating issues
around emotional distress. It has been suggested that distress
should be considered the ‘6th Vital Sign’, after blood pressure,
temperature, respiration, pulse, and pain. This push could lead to
more routine consideration of distress, in the same manner the
pain community has raised awareness by referring to it as the ‘5th
vital sign’. The NCCN has worked to develop distress screening
and treatment guidelines, as outlined in the introduction, but the
challenge now is to facilitate the implementation of screening and
triage into routine clinical care. Some models have been
successfully utilised in research settings including the use of
computerised questionnaires, often web-based or using hand-held
PDAs. The data supporting the feasibility of computer-based
technology is convincing, in terms of its reliability, acceptability to
patients, and utility in improving clinical care around psychosocial
issues (Taenzer et al., 1997; Velikova et al., 1999; Taenzer et al.,
2000; McLachlan et al., 2001; Carlson et al., 2001; Bezjak et al.,
2001). This may be one avenue well worth pursuing in the effort to
ensure that all patients are screened and appropriately referred for
treatment of the distress that so commonly accompanies cancer
diagnosis and treatment.
Treatment models themselves may also have to change in face
of the patient profile that may result from the implementation
of routine screening. With more broad-based screening efforts
and less self-referral, the demographic may shift from primarily
articulate, socially competent female patients towards those
who are less verbal with fewer social skills, addiction histories,
or compliance problems, who may not have sought
out psychosocial support otherwise. The caseload may also shift
from primarily women towards a more even balance of men and
women, and more head and neck cancer patients. This patient
population may not respond as well to the traditional ‘talk therapy’
often used to treat cancer-related distress, and be more amenable
to behavioural and problem-solving interventions. Thus,
the model of changing care may well look like the stages
model suggested by Cunningham, who has identified a hierarchy
of different types of group therapy, based on increasingly
active participation by the recipient. The five types are described
as: providing information, emotional support, behavioural
training in coping skills, psychotherapy, and finally spiritual/
existential therapy (Cunningham, 1995). Thus, a patient could
begin by attending a large-group format psychoeducational
workshop, and seek further intensive therapy if necessary, at their
discretion.
This study serves to highlight a problem that has by now been
well documented, and begs further directions and innovations in
distress treatment. The best solution may be a marriage between
appropriate screening using versatile technology, and program-
matic assessment and triage at critical times during the cancer
experience. If this can be integrated with a range of empirically
based psychosocial treatment options, the most efficient and
efficacious model of patient care is likely to result.
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